Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Lung Cancer|Colorectal Cancer|Liver Cancer|Pancreatic Cancer|Gastric Cancer|Breast Cancer
Interventions: BIOLOGICAL: CEA CAR-T cells
Sponsor: Chongqing Precision Biotech Co., Ltd